Biomarkers Change
Everything
Better biology. Better data. Better trials.
SplashBIO™ is built on the science that enables smarter enrollment before traditional screening begins.
The Science Behind Smarter Enrollment
Biomarker, digital, and remote assessments work together to improve trial readiness, pre-screen more accurately, and reduce costly screen failures.
Fluid Biomarkers
Blood and saliva biomarkers that reflect disease biology.
Genetic Insights
Genetic testing to characterize risk, subtype, and underlying biology.
Digital & Cognitive
Digital cognitive and real-world data for deeper phenotyping and outcome modelling.
Remote Assessments
Decentralized evaluations that expand access and improve data quality.
Built on Rigor.
Designed for Impact.
Our scientific approach is evidence-based, adaptive, and built to deliver real-world impact.
Evidence-Based
Science-backed approaches rooted in peer-reviewed research.
Multi-Modal
Combining biomarkers, genetics, digital, and clinical data for a complete picture.
Enrichment
Biomarker-informed analytics help identify likely-eligible patients and improve trial efficiency.
Biomarker Science
Built on biomarker science, using assays and assessments applied in real-world studies and clinical trials.
Adaptive
Continuously learning to improve accuracy and trial performance.
From Science to Better Trials
Understand Biology
Quantify and characterize biomarkers associated with disease stage and progression.
Pre-Screen for Eligibility
Match biomarker and clinical profiles to trial criteria more effectively.
Enrich the Trial
Refer patients whose biomarker profile increases the likelihood of protocol eligibility.
Improve Outcomes
Higher signal, fewer failures, faster path to meaningful results.
*Not a diagnosis. Eligibility is confirmed by the site's protocol screening.
Better Science.
Better Trials.
Let’s build the future of enrollment—together.